출판 : MarketsandMarkets (마켓츠앤마켓츠) 출판년월 : 2023년02월
생명 과학 분석 시장 : 유형(예측, 설명, 규범), 용도(영업 및 마케팅, 규제 대응, R&D, 파마코비지란스), 구성 요소(소프트웨어, 서비스), 배포(온프레미스, 온디맨드), 최종 사용자 – 2027년까지의 세계 예측
Life Science Analytics Market by Type (Predictive, Descriptive, Prescriptive), Application(Sales & Marketing, Regulatory Compliance, R&D , Pharmacovigilance), Component(Software, Service), Delivery (On Premise, On Demand), End User -Global Forecast to 2027
| 페이지수 | 243 |
| 도표수 | 254 |
| 구성 | 영문조사보고서 |
| 가격 |
The life science analytics market is projected to reach USD 47.5 billion by 2027 from USD 27.1 billion in 2022, at a CAGR of 11.8% during the forecast period. Growth in this market is mainly driven by rising pressure to curb healthcare spending, the rising need for improved data standardization, and the increasing adoption of analytical solutions in clinical trials. On the other hand, a high implementation price is expected to restrain the growth of this market.
생명과학 분석 시장은 2022년 271억 달러에서 2027년까지 475억 달러에 달할 것으로 예측 기간 동안 연평균 11.8% 성장할 것으로 예상됩니다. 이 시장의 성장은 주로 의료 지출을 억제하라는 압력 증가, 데이터 표준화 개선의 필요성 증가, 임상 시험에서 분석 솔루션의 채택 증가에 의해 주도됩니다. 한편, 높은 구현 가격은 이 시장의 성장을 억제할 것으로 예상됩니다.
Descriptive analytics type segment holds the largest share of the life science analytics market in 2021”
On the basis of type, the life science analytics market is bifurcated into descriptive, predictive, and prescriptive analytics. The descriptive analytics segment accounted for the largest market share in 2021. Due to its ability to confirm the synergistic integration of predictions and prescriptions, prescriptive analytics segment is projected to grow at the highest CAGR during the forecast period.
“Services segment accounted for the largest share of the life science analytics market in 2021.”
On the basis of component, the life science analytics market is bifurcated into services and software. The services segment accounted for the largest market share in 2021 and is expected to register the highest growth during the forecast period. The large share and high growth in this segment can be attributed to the frequent need for services such as software upgrades and maintenance.
“Asia Pacific to be the fastest-growing regional market in 2021.”
On the basis of region, the life science analytics market is bifurcated into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2021, North America accounted for the largest market share. The large share of this market is attributed to the strong economies in the US and Canada, which have allowed for considerable investments in technology in this region. However, Asia Pacific is expected to grow at the highest CAGR during the forecast period. Factors such as the rising adoption of advanced technologies, the increasing growth in the life science industry, and the growing focus of major players on increasing their presence in emerging APAC countries are expected to drive market growth in this regional segment.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 (32%), Tier 2 (44%), and Tier 3 (24%)
• By Designation: C-level (30%), D-level (34%), and Others (36%)
• By Region: North America (40%), Europe (28%), Asia Pacific (20%), and the RoW (12%)
Prominent players in this market include Oracle (US), IBM (US), SAS Institute Inc. (US), Accenture (Ireland), IQVIA Inc, (US), Cognizant (US), Wipro (India), Allscripts Healthcare, LLC (US), Optum, Inc. (US), Microsoft (US), MaxisIT (US), ExlService Holdings, Inc. (US), Cerner Corporation (US), Cotiviti, Inc. (US), Inovalon (US), CitiusTech Inc (US), Saama Technologies, LLC. (US), Axtria (US), Clarivate (UK), ThoughtSphere (US), ThoughtSpot Inc. (US), Alteryx, Inc. (US), Sisense Inc. (US), Amazon Web Services, Inc., and Veeva Systems (US).
Research Coverage:
This report provides a picture of the life science analytics market. It aims at estimating the size and future growth potential of the market across different segments, such as type, component, deployment model, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall life science analytics market and its subsegments. This report will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. It will also enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, challenges, and opportunities.
목차
1 INTRODUCTION 32
1.1 STUDY OBJECTIVES 32
1.2 MARKET DEFINITION 32
1.2.1 INCLUSIONS AND EXCLUSIONS 32
1.3 MARKET SCOPE 33
1.3.1 MARKETS COVERED 33
FIGURE 1 LIFE SCIENCE ANALYTICS: MARKET SEGMENTATION 33
1.3.2 YEARS CONSIDERED 34
1.4 CURRENCY CONSIDERED 34
1.5 STAKEHOLDERS 34
1.6 SUMMARY OF CHANGES 34
1.7 RECESSION IMPACT 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DATA 36
2.2 RESEARCH METHODOLOGY DESIGN 36
FIGURE 2 LIFE SCIENCE ANALYTICS MARKET: RESEARCH DESIGN 36
2.2.1 SECONDARY SOURCES 37
2.2.1.1 Key data from secondary sources 37
2.2.2 PRIMARY SOURCES 38
FIGURE 3 PRIMARY SOURCES 38
2.2.2.1 Key data from primary sources 39
2.2.2.2 Key industry insights 40
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS 40
2.3 MARKET SIZE ESTIMATION 41
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 41
FIGURE 6 LIFE SCIENCE ANALYTICS MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION 42
FIGURE 7 BOTTOM-UP APPROACH 43
FIGURE 8 LIFE SCIENCE ANALYTICS MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027) 44
FIGURE 9 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS 45
FIGURE 10 TOP-DOWN APPROACH 45
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 46
FIGURE 11 DATA TRIANGULATION METHODOLOGY 47
2.5 MARKET SHARE ESTIMATION 47
2.6 STUDY ASSUMPTIONS 48
2.7 LIMITATIONS 48
2.7.1 METHODOLOGY-RELATED LIMITATIONS 48
2.7.2 SCOPE-RELATED LIMITATIONS 48
2.8 RISK ASSESSMENT 49
TABLE 1 LIFE SCIENCE ANALYTICS MARKET: RISK ASSESSMENT 49
2.9 LIFE SCIENCE ANALYTICS MARKET: RECESSION IMPACT 49
3 EXECUTIVE SUMMARY 50
FIGURE 12 LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 50
FIGURE 13 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 51
FIGURE 14 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION) 51
FIGURE 15 LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2022 VS. 2027 (USD MILLION) 52
FIGURE 16 LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 52
FIGURE 17 LIFE SCIENCE ANALYTICS MARKET: GEOGRAPHICAL SNAPSHOT 53
4 PREMIUM INSIGHTS 54
4.1 LIFE SCIENCE ANALYTICS MARKET OVERVIEW 54
FIGURE 18 RISING TECHNOLOGICAL ADVANCEMENTS AND GROWING ADOPTION OF ANALYTICS SOLUTIONS FOR CLINICAL TRIALS TO DRIVE MARKET 54
4.2 LIFE SCIENCE ANALYTICS MARKET, BY TYPE 55
FIGURE 19 DESCRIPTIVE ANALYTICS SEGMENT TO DOMINATE MARKET IN 2021 55
4.3 LIFE SCIENCE ANALYTICS MARKET, BY END USER & REGION 56
FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2021 56
4.4 LIFE SCIENCE ANALYTICS MARKET: GEOGRAPHIC SNAPSHOT 57
FIGURE 21 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 57
5 MARKET OVERVIEW 58
5.1 INTRODUCTION 58
5.2 MARKET DYNAMICS 58
FIGURE 22 LIFE SCIENCE ANALYTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 58
5.2.1 DRIVERS 59
5.2.1.1 Rising pressure to curb healthcare spending 59
FIGURE 23 HEALTHCARE SPENDING AS A PERCENTAGE OF GDP, BY COUNTRY (2019) 59
5.2.1.2 Rising need for improved data standardization 60
5.2.1.3 Rising technological advancements in analytical solutions 60
5.2.1.4 Impact of big data on life science 61
5.2.1.5 Growing adoption of analytical solutions in clinical trials 61
5.2.1.6 Increasing adoption of analytics for sales & marketing applications 62
5.2.2 RESTRAINTS 62
5.2.2.1 High implementation cost of advanced analytical solutions 62
5.2.2.2 Data privacy concerns 62
5.2.3 OPPORTUNITIES 63
5.2.3.1 Growing focus on value-based care 63
5.2.3.2 Use of analytics in precision & personalized medicine 63
5.2.3.3 Big data analytics for R&D productivity 64
5.2.4 CHALLENGES 64
5.2.4.1 Issues associated with data integration 64
5.2.4.2 Shortage of skilled personnel 64
5.3 ECOSYSTEM ANALYSIS 65
5.4 VALUE CHAIN ANALYSIS 66
FIGURE 24 LIFE SCIENCE ANALYTICS MARKET: VALUE CHAIN ANALYSIS 66
5.5 PORTER’S FIVE FORCES ANALYSIS 67
5.5.1 THREAT FROM NEW ENTRANTS 67
5.5.2 THREAT FROM SUBSTITUTES 68
5.5.3 BARGAINING POWER OF SUPPLIERS 68
5.5.4 BARGAINING POWER OF BUYERS 68
5.5.5 INTENSITY OF COMPETITIVE RIVALRY 68
5.6 TECHNOLOGY ANALYSIS 69
5.6.1 MACHINE LEARNING 69
5.6.2 ARTIFICIAL INTELLIGENCE 69
5.6.3 INTERNET OF THINGS 69
5.6.4 BIG DATA 69
5.7 INDUSTRY TRENDS 70
5.7.1 INCREASING PARTNERSHIPS & COLLABORATIONS FOR INNOVATION 70
5.7.2 GROWING DEMAND FOR AI IN PHARMACEUTICAL INDUSTRY 70
5.8 CASE STUDY ANALYSIS 71
5.8.1 CASE STUDY 1 71
5.8.2 CASE STUDY 2 71
5.8.3 CASE STUDY 3 71
5.9 REGULATORY ANALYSIS 72
5.9.1 NORTH AMERICA 72
5.9.2 EUROPE 73
5.9.3 ASIA PACIFIC 73
5.9.4 MIDDLE EAST & AFRICA 74
5.9.5 LATIN AMERICA 74
5.10 PRICING ANALYSIS 74
TABLE 2 AVERAGE SELLING PRICE OF LIFE SCIENCE ANALYTICS SOLUTIONS, BY APPLICATION 75
5.10.1 AVERAGE SELLING PRICE TREND ANALYSIS 75
5.11 KEY CONFERENCES AND EVENTS IN 2022–2023 75
TABLE 3 LIFE SCIENCE ANALYTICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 75
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 76
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 76
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 76
TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS (%) 77
5.12.2 BUYING CRITERIA 77
FIGURE 26 KEY BUYING CRITERIA FOR END USERS 77
TABLE 5 KEY BUYING CRITERIA FOR END USERS 77
6 LIFE SCIENCE ANALYTICS MARKET, BY TYPE 78
6.1 INTRODUCTION 79
TABLE 6 LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 79
6.2 DESCRIPTIVE ANALYTICS 79
6.2.1 ABILITY TO BE IMPLEMENTED WITH STANDARD AGGREGATE FUNCTIONS TO DRIVE MARKET 79
TABLE 7 DESCRIPTIVE ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION) 80
TABLE 8 NORTH AMERICA: DESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 80
TABLE 9 EUROPE: DESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 80
TABLE 10 ASIA PACIFIC: DESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3 PREDICTIVE ANALYTICS 81
6.3.1 SIMULATIONS DEVELOPMENT FOR PREDICTION OF FUTURE TRENDS TO DRIVE MARKET 81
TABLE 11 PREDICTIVE ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION) 82
TABLE 12 NORTH AMERICA: PREDICTIVE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 82
TABLE 13 EUROPE: PREDICTIVE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 82
TABLE 14 ASIA PACIFIC: PREDICTIVE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 83
6.4 PRESCRIPTIVE ANALYTICS 83
6.4.1 REAL-TIME ANALYSIS FOR IMPROVED DECISION-MAKING TO SUPPORT MARKET GROWTH 83
TABLE 15 PRESCRIPTIVE ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION) 84
TABLE 16 NORTH AMERICA: PRESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 84
TABLE 17 EUROPE: PRESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 84
TABLE 18 ASIA PACIFIC: PRESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 85
7 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 19 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 87
7.2 RESEARCH & DEVELOPMENT 87
TABLE 20 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE R&D SOLUTIONS 88
TABLE 21 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2020–2027 (USD MILLION) 88
TABLE 22 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION) 89
TABLE 23 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION) 89
TABLE 24 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION) 89
TABLE 25 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION) 90
7.2.1 CLINICAL TRIALS 90
7.2.1.1 Rising need to streamline clinical data and reduce time & costs to drive market 90
TABLE 26 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE CLINICAL TRIAL SOLUTIONS 91
TABLE 27 LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY REGION, 2020–2027 (USD MILLION) 91
TABLE 28 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY COUNTRY, 2020–2027 (USD MILLION) 91
TABLE 29 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY COUNTRY, 2020–2027 (USD MILLION) 92
TABLE 30 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.2 PRECLINICAL TRIALS 92
7.2.2.1 Ability to assist researchers in process innovation and decision support to drive adoption 92
TABLE 31 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE PRECLINICAL TRIAL SOLUTIONS 93
TABLE 32 LIFE SCIENCE ANALYTICS MARKET FOR PRECLINICAL TRIALS, BY REGION, 2020–2027 (USD MILLION) 93
TABLE 33 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR PRECLINICAL TRIALS, BY COUNTRY, 2020–2027 (USD MILLION) 93
TABLE 34 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR PRECLINICAL TRIALS, BY COUNTRY, 2020–2027 (USD MILLION) 94
TABLE 35 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR PRECLINICAL TRIALS, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.3 SALES & MARKETING 94
7.3.1 RISING ANALYSIS OF DIGITAL MARKETING EFFECTIVENESS TO DRIVE ADOPTION 94
TABLE 36 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE SALES & MARKETING SOLUTIONS 95
TABLE 37 LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING, BY REGION, 2020–2027 (USD MILLION) 95
TABLE 38 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING, BY COUNTRY, 2020–2027 (USD MILLION) 96
TABLE 39 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING, BY COUNTRY, 2020–2027(USD MILLION) 96
TABLE 40 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 PHARMACOVIGILANCE 97
7.4.1 MONITORING OF DRUG TRIALS AND MEDICATION PROGRAMS TO FUEL MARKET UPTAKE 97
TABLE 41 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE PHARMACOVIGILANCE SOLUTIONS 97
TABLE 42 LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY REGION, 2020–2027 (USD MILLION) 97
TABLE 43 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY COUNTRY, 2020–2027 (USD MILLION) 98
TABLE 44 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY COUNTRY, 2020–2027 (USD MILLION) 98
TABLE 45 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY COUNTRY, 2020–2027 (USD MILLION) 98
7.5 REGULATORY COMPLIANCE 99
7.5.1 STRINGENT REQUIREMENTS FOR COMPLIANCE ADHERENCE TO DRIVE ADOPTION OF SOLUTIONS 99
TABLE 46 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE REGULATORY COMPLIANCE SOLUTIONS 99
TABLE 47 LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY REGION, 2020–2027 (USD MILLION) 99
TABLE 48 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY COUNTRY, 2020–2027(USD MILLION) 100
TABLE 49 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY COUNTRY, 2020–2027 (USD MILLION) 100
TABLE 50 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY COUNTRY, 2020–2027 (USD MILLION) 100
7.6 SUPPLY CHAIN OPTIMIZATION 101
7.6.1 RISING NEED TO REDUCE LOGISTICS COSTS TO SUPPORT MARKET GROWTH 101
TABLE 51 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE SUPPLY CHAIN OPTIMIZATION SOLUTIONS 101
TABLE 52 LIFE SCIENCE ANALYTICS MARKET FOR SUPPLY CHAIN OPTIMIZATION, BY REGION, 2020–2027 (USD MILLION) 101
TABLE 53 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR SUPPLY CHAIN OPTIMIZATION, BY COUNTRY, 2020–2027 (USD MILLION) 102
TABLE 54 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR SUPPLY CHAIN OPTIMIZATION, BY COUNTRY, 2020–2027 (USD MILLION) 102
TABLE 55 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR SUPPLY CHAIN OPTIMIZATION, BY COUNTRY, 2020–2027 (USD MILLION) 102
8 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT 103
8.1 INTRODUCTION 104
TABLE 56 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027(USD MILLION) 104
8.2 SERVICES 104
8.2.1 INCREASING UTILIZATION OF SERVICE PROVIDERS FOR IMPLEMENTATION AND MAINTENANCE OF ANALYTICS TO DRIVE MARKET 104
TABLE 57 LIFE SCIENCE ANALYTICS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 105
TABLE 58 NORTH AMERICA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 105
TABLE 59 EUROPE: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 106
TABLE 60 ASIA PACIFIC: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 106
8.3 SOFTWARE 106
8.3.1 RISING NEED TO MANAGE CLINICAL TRIALS DATA BY PHARMA-BIOTECH COMPANIES TO DRIVE ADOPTION 106
TABLE 61 LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION) 107
TABLE 62 NORTH AMERICA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 108
TABLE 63 EUROPE: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 108
TABLE 64 ASIA PACIFIC: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 108
9 LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL 109
9.1 INTRODUCTION 110
TABLE 65 LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION) 110
9.2 ON-PREMISE DELIVERY MODEL 110
9.2.1 PROVISION OF MULTI-VENDOR ARCHITECTURE AND SECURITY BENEFITS TO DRIVE MARKET 110
TABLE 66 LIFE SCIENCE ANALYTICS MARKET FOR ON-PREMISE DELIVERY MODEL, BY REGION, 2020–2027 (USD MILLION) 111
TABLE 67 NORTH AMERICA: LIFE SCIENCE ANALYTICS SOLUTIONS MARKET FOR ON-PREMISE DELIVERY MODEL, BY COUNTRY, 2020–2027 (USD MILLION) 111
TABLE 68 EUROPE: LIFE SCIENCE ANALYTICS SOLUTIONS MARKET FOR ON-PREMISE DELIVERY MODEL, BY COUNTRY, 2020–2027 (USD MILLION) 111
TABLE 69 ASIA PACIFIC: LIFE SCIENCE ANALYTICS SOLUTIONS MARKET FOR ON-PREMISE DELIVERY MODEL, BY COUNTRY, 2020–2027 (USD MILLION) 112
9.3 ON-DEMAND DELIVERY MODEL 112
9.3.1 REAL-TIME ANALYSIS AND ELIMINATION OF PURCHASING COSTS FOR SOFTWARE & HARDWARE TO DRIVE ADOPTION 112
TABLE 70 LIFE SCIENCE ANALYTICS MARKET: ON-DEMAND SOLUTIONS OFFERED 113
TABLE 71 LIFE SCIENCE ANALYTICS SOLUTIONS MARKET FOR ON-DEMAND DELIVERY MODEL, BY REGION, 2020–2027 (USD MILLION) 113
TABLE 72 NORTH AMERICA: LIFE SCIENCE ANALYTICS SOLUTIONS MARKET FOR ON-DEMAND DELIVERY MODEL, BY COUNTRY, 2020–2027 (USD MILLION) 114
TABLE 73 EUROPE: LIFE SCIENCE ANALYTICS SOLUTIONS MARKET FOR ON-DEMAND DELIVERY MODEL, BY COUNTRY, 2020–2027 (USD MILLION) 114
TABLE 74 ASIA PACIFIC: LIFE SCIENCE ANALYTICS SOLUTIONS MARKET FOR ON-DEMAND DELIVERY MODEL, BY COUNTRY, 2020–2027 (USD MILLION) 114
10 LIFE SCIENCE ANALYTICS MARKET, BY END USER 115
10.1 INTRODUCTION 116
TABLE 75 LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 116
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 116
10.2.1 RISING NEED FOR INNOVATIVE THERAPIES TO ADOPT ANALYTICS FOR PRODUCT DEVELOPMENT 116
TABLE 76 LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION) 117
TABLE 77 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 118
TABLE 78 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 118
TABLE 79 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 118
10.3 MEDICAL DEVICE COMPANIES 119
10.3.1 ADOPTION OF BIG DATA ANALYTICS FOR COMMERCIALIZATION OF DEVICES TO DRIVE MARKET 119
TABLE 80 LIFE SCIENCE ANALYTICS MARKET: KEY SOLUTIONS OFFERED BY COMPANIES 119
TABLE 81 LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2020–2027 (USD MILLION) 119
TABLE 82 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 119
TABLE 83 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 120
TABLE 84 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 120
10.4 RESEARCH CENTERS 120
10.4.1 ANALYZATION OF LARGE VOLUMES OF DATA DUE TO INCREASING RESEARCH ACTIVITIES TO SUPPORT MARKET GROWTH 120
TABLE 85 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY REGION, 2020–2027 (USD MILLION) 121
TABLE 86 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY COUNTRY, 2020–2027 (USD MILLION) 121
TABLE 87 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY COUNTRY, 2020–2027 (USD MILLION) 121
TABLE 88 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY COUNTRY, 2020–2027 (USD MILLION) 122
10.5 THIRD-PARTY ADMINISTRATORS (TPAS) 122
10.5.1 RISING R&D OUTSOURCING BY LIFE SCIENCE COMPANIES TO DRIVE MARKET GROWTH 122
TABLE 89 LIFE SCIENCE ANALYTICS MARKET FOR THIRD-PARTY ADMINISTRATORS, BY REGION, 2020–2027 (USD MILLION) 122
TABLE 90 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR THIRD-PARTY ADMINISTRATORS, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 91 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR THIRD-PARTY ADMINISTRATORS, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 92 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR THIRD-PARTY ADMINISTRATORS, BY COUNTRY, 2020–2027 (USD MILLION) 123
11 LIFE SCIENCE ANALYTICS MARKET, BY REGION 124
11.1 INTRODUCTION 125
TABLE 93 LIFE SCIENCE ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION) 125
11.2 NORTH AMERICA 125
FIGURE 27 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET SNAPSHOT 126
11.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS 127
TABLE 94 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 127
TABLE 95 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 127
TABLE 96 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 97 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 98 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 128
TABLE 99 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION) 129
TABLE 100 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
11.2.2 US 129
11.2.2.1 Established economy and increasing R&D expenditure to drive adoption of analytical solutions 129
TABLE 101 US: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 130
TABLE 102 US: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 103 US: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 104 US: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 131
TABLE 105 US: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION) 132
TABLE 106 US: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 132
11.2.3 CANADA 132
11.2.3.1 Rising need for data standardization in life sciences to fuel uptake 132
TABLE 107 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 133
TABLE 108 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 133
TABLE 109 CANADA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 134
TABLE 110 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 134
TABLE 111 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION) 134
TABLE 112 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 135
11.3 EUROPE 135
11.3.1 EUROPE: RECESSION IMPACT ANALYSIS 135
TABLE 113 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 136
TABLE 114 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 115 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 136
TABLE 116 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 137
TABLE 117 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 137
TABLE 118 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION) 137
TABLE 119 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 138
11.3.2 GERMANY 138
11.3.2.1 Growing R&D investments by pharmaceutical & biotechnology companies to drive market 138
TABLE 120 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 121 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 122 GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 123 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 140
TABLE 124 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION) 140
TABLE 125 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 140
11.3.3 FRANCE 141
11.3.3.1 Growing government support for adoption of AI & big data analytics to drive market 141
TABLE 126 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 141
TABLE 127 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 128 FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 142
TABLE 129 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 142
TABLE 130 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027(USD MILLION) 143
TABLE 131 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 143
11.3.4 UK 143
11.3.4.1 Growing number of clinical trials to drive uptake of life science analytics solutions 143
TABLE 132 UK: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 144
TABLE 133 UK: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 144
TABLE 134 UK: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 144
TABLE 135 UK: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 145
TABLE 136 UK: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION) 145
TABLE 137 UK: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 145
11.3.5 ITALY 146
11.3.5.1 Growing number of drug approvals to drive uptake of analytics solutions 146
TABLE 138 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 139 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 146
TABLE 140 ITALY: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 141 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 147
TABLE 142 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027(USD MILLION) 147
TABLE 143 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 147
11.3.6 REST OF EUROPE 148
TABLE 144 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 148
TABLE 145 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 148
TABLE 146 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 149
TABLE 147 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 149
TABLE 148 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION) 149
TABLE 149 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 150
11.4 ASIA PACIFIC 150
FIGURE 28 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET SNAPSHOT 151
11.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS 151
TABLE 150 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 152
TABLE 151 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 152 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 153
TABLE 153 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 153
TABLE 154 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 153
TABLE 155 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION) 154
TABLE 156 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 154
11.4.2 JAPAN 154
11.4.2.1 Growing government support for clinical R&D activities to drive adoption 154
TABLE 157 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 158 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 155
TABLE 159 JAPAN: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 156
TABLE 160 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 156
TABLE 161 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION) 156
TABLE 162 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 156
11.4.3 CHINA 157
11.4.3.1 Growth in life science industry to support adoption of solutions 157
TABLE 163 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 157
TABLE 164 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 165 CHINA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 158
TABLE 166 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 158
TABLE 167 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION) 159
TABLE 168 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 159
11.4.4 INDIA 159
11.4.4.1 Rising R&D expenditure and growing number of drug development activities to support market growth 159
TABLE 169 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 170 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 160
TABLE 171 INDIA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 161
TABLE 172 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 161
TABLE 173 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION) 161
TABLE 174 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 161
11.4.5 REST OF ASIA PACIFIC 162
TABLE 175 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 176 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 177 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 163
TABLE 178 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 163
TABLE 179 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION) 163
TABLE 180 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 164
11.5 REST OF THE WORLD 164
11.5.1 REST OF THE WORLD: RECESSION IMPACT ANALYSIS 164
TABLE 181 REST OF THE WORLD: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 165
TABLE 182 REST OF THE WORLD: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 166
TABLE 183 REST OF THE WORLD: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 184 REST OF THE WORLD: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION) 166
TABLE 185 REST OF THE WORLD: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020–2027 (USD MILLION) 167
TABLE 186 REST OF THE WORLD: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
12 COMPETITIVE LANDSCAPE 168
12.1 INTRODUCTION 168
12.2 STRATEGIES ADOPTED BY KEY PLAYERS 168
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS 169
12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 170
FIGURE 29 LIFE SCIENCE ANALYTICS MARKET: REVENUE SHARE ANALYSIS OF KEY PLAYERS 170
12.4 MARKET RANKING ANALYSIS, 2021 171
FIGURE 30 LIFE SCIENCE ANALYTICS MARKET: MARKET RANKING ANALYSIS (2021) 171
12.5 COMPETITIVE LEADERSHIP MAPPING 172
12.5.1 STARS 172
12.5.2 PERVASIVE PLAYERS 172
12.5.3 EMERGING LEADERS 172
12.5.4 PARTICIPANTS 172
FIGURE 31 COMPETITIVE LEADERSHIP MAPPING FOR KEY PLAYERS (2021) 173
12.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS 173
12.6.1 PROGRESSIVE COMPANIES 173
12.6.2 STARTING BLOCKS 173
12.6.3 RESPONSIVE COMPANIES 174
12.6.4 DYNAMIC COMPANIES 174
FIGURE 32 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS (2021) 174
12.7 COMPETITIVE BENCHMARKING 175
TABLE 187 LIFE SCIENCE ANALYTICS MARKET: OVERALL COMPANY FOOTPRINT 175
TABLE 188 LIFE SCIENCE ANALYTICS MARKET: APPLICATION FOOTPRINT OF COMPANIES 175
TABLE 189 LIFE SCIENCE ANALYTICS MARKET: COMPONENT FOOTPRINT OF COMPANIES 176
TABLE 190 LIFE SCIENCE ANALYTICS MARKET: REGIONAL FOOTPRINT OF COMPANIES 176
12.8 COMPETITIVE SCENARIO 176
12.8.1 PRODUCT/SERVICE LAUNCHES/ENHANCEMENTS 177
TABLE 191 KEY PRODUCT/SERVICE LAUNCHES/ENHANCEMENTS (JANUARY 2019─DECEMBER 2022) 177
12.8.2 DEALS 178
TABLE 192 DEALS (JANUARY 2019─DECEMBER 2022) 178
12.8.3 OTHER DEVELOPMENTS 179
TABLE 193 OTHER DEVELOPMENTS (JANUARY 2019─DECEMBER 2022) 179
13 COMPANY PROFILES 180
13.1 KEY PLAYERS 180
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1 ORACLE 180
TABLE 194 ORACLE: COMPANY OVERVIEW 180
FIGURE 33 ORACLE: COMPANY SNAPSHOT (2022) 181
13.1.2 IBM 184
TABLE 195 IBM: COMPANY OVERVIEW 184
FIGURE 34 IBM: COMPANY SNAPSHOT (2021) 185
13.1.3 SAS INSTITUTE INC. 188
TABLE 196 SAS INSTITUTE INC.: COMPANY OVERVIEW 188
FIGURE 35 SAS INSTITUTE INC.: COMPANY SNAPSHOT (2021) 189
13.1.4 ACCENTURE 192
TABLE 197 ACCENTURE: COMPANY OVERVIEW 192
FIGURE 36 ACCENTURE: COMPANY SNAPSHOT (2021) 193
13.1.5 IQVIA INC. 196
TABLE 198 IQVIA INC.: COMPANY OVERVIEW 196
FIGURE 37 IQVIA INC.: COMPANY SNAPSHOT (2021) 197
13.1.6 COGNIZANT 201
TABLE 199 COGNIZANT: COMPANY OVERVIEW 201
FIGURE 38 COGNIZANT: COMPANY SNAPSHOT (2021) 202
13.1.7 WIPRO 205
TABLE 200 WIPRO: COMPANY OVERVIEW 205
FIGURE 39 WIPRO: COMPANY SNAPSHOT (2022) 206
13.1.8 ALLSCRIPTS HEALTHCARE, LLC 209
TABLE 201 ALLSCRIPTS HEALTHCARE, LLC: COMPANY OVERVIEW 209
FIGURE 40 ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT (2021) 210
13.1.9 OPTUM, INC. 212
TABLE 202 OPTUM, INC.: COMPANY OVERVIEW 212
FIGURE 41 OPTUM, INC.: COMPANY SNAPSHOT (2021) 212
13.1.10 MICROSOFT 214
TABLE 203 MICROSOFT: COMPANY OVERVIEW 214
FIGURE 42 MICROSOFT: COMPANY SNAPSHOT (2021) 215
13.1.11 MAXISIT 218
TABLE 204 MAXISIT: COMPANY OVERVIEW 218
13.1.12 EXLSERVICE HOLDINGS, INC. 220
TABLE 205 EXLSERVICE HOLDINGS, INC.: COMPANY OVERVIEW 220
FIGURE 43 EXLSERVICE HOLDINGS, INC.: COMPANY SNAPSHOT (2021) 221
13.1.13 CERNER CORPORATION 223
TABLE 206 CERNER CORPORATION: COMPANY OVERVIEW 223
FIGURE 44 CERNER CORPORATION: COMPANY SNAPSHOT (2021) 224
13.1.14 INOVALON 226
TABLE 207 INOVALON: COMPANY OVERVIEW 226
13.1.15 CITIUSTECH INC. 228
TABLE 208 CITIUSTECH INC.: COMPANY OVERVIEW 228
13.1.16 SAAMA TECHNOLOGIES, LLC 230
TABLE 209 SAAMA TECHNOLOGIES, LLC: COMPANY OVERVIEW 230
13.1.17 AXTRIA 233
TABLE 210 AXTRIA: COMPANY OVERVIEW 233
13.1.18 CLARIVATE 235
TABLE 211 CLARIVATE: COMPANY OVERVIEW 235
FIGURE 45 CLARIVATE: COMPANY SNAPSHOT (2021) 236
13.2 OTHER COMPANIES 238
13.2.1 THOUGHTSPHERE 238
13.2.2 THOUGHTSPOT, INC. 239
13.2.3 ALTERYX, INC. 240
13.2.4 SISENSE INC. 241
13.2.5 COTIVITI, INC. 241
13.2.6 AMAZON WEB SERVICES, INC. 242
13.2.7 VEEVA SYSTEMS 243
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX 244
14.1 DISCUSSION GUIDE 244
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 248
14.3 CUSTOMIZATION OPTIONS 250
14.4 RELATED REPORTS 250
14.5 AUTHOR DETAILS 251
